Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Oct 21, 2019 (7 years ago)

PF-Succinylcholine Chloride Injection

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Incorrect labeling: Incorrect or missing lot and/or exp date

Cause type: Labeling / mix-up

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.

What was recalled

PF-Succinylcholine Chloride Injection, USP 20 mg/mL (200 mg/10 mL), Rx Only, Single-Dose Container, 5 x 10 mL pre-filled syringes, Nephron 503B Outsourcing Facility 4500 12th St. Ext West Columbia, SC 29172, NDC 69374-919-10.

Affected NDC 69374-0919-10

Compare with the code on your package — it is the most precise check available.

Drug: Succinylcholine

Recalling firm
Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center
NDC code
69374-919-10
Origin
SC, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0154-2020 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Succinylcholine recalls

See all
Class II · Moderate risk

Succinylcholine Chloride Injection

Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation impurity.

Ongoing Impurity / degradation Zydus Pharmaceuticals (USA) Inc NDC 70710-1377-1 D-0623-2025

Other recalls by Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center

All 2019 recalls